Scientists discovered genetic cause for rare disorder of motor neurones

December 7, 2012 in Genetics

(Medical Xpress)—Scientists have identified an underlying genetic cause for a rare disorder of motor neurones, and believe this may help find causes of other related diseases.

Disorders of motor neurones are a group of progressive that damage the nervous system, causing and wasting. These diseases affect many thousands of people in the UK. A number are inherited but the causes of the majority remain unknown, and there are no cures.

The new study has discovered a that causes a rare disorder of motor neurones called distal hereditary motor neuropathy (dHMN). The researchers say their findings raise a possibility that mutations of the same gene or genes with similar roles might underlie other disorders of motor neurones. This could open up the potential for new treatment options, not only for dHMN but also for the wider group of these disorders.

dHMN principally affects muscles of the hands and feet, and sometimes causes a hoarse voice. Symptoms usually begin during adolescence although this can vary from infancy to the mid-thirties.

The study to investigate possible genetic causes of dHMN was led by Professor Andrew Crosby and Dr Meriel McEntagart at St George's, University of London. It has been published in the .

The researchers carried out genetic sequencing of 26 members of one family in which 14 members were affected by dHMN and 12 were not. The mutation was found in all the affected members of the family.

The mutation of the gene – called SLC5A7 – was found to disrupt the function of a molecule called the choline transporter (CHT). CHT is responsible for carrying an essential nutrient called choline to the neuromuscular junctions, the areas in the body where nerves meet muscles and that are essential for motor function. This disruption to the function of the neuromuscular junctions leads to the debilitating symptoms.

Mutations of other genes affecting the function of the are known to cause other unrelated neuromuscular disorders. But this is the first time a mutation affecting these specific areas has been linked to any disorder of motor neurones.

Professor Andrew Crosby of St George's, University of London said: "This genetic mechanism has never been linked with a disorder of motor neurones, so it indicates a new biological basis for this group of conditions. Knowledge of the biological pathway related to dHMN will potentially allow us to develop possible treatment options."

Professor Crosby said the latest findings about dHMN will enable them to conduct genetic testing for risk of this rare disease in affected families, using an existing assay. This should also allow them to test for risk of other disorders related to the same mechanism.

"This a very promising step that may provide clues about other unexplained disorders of motor neurones caused by a similar biological disease mechanism", added Professor Crosby.

"A goal now is to investigate this biological mechanism in other patients with unexplained degenerative disorders of motor neurones."

More information: dx.doi.org/10.1016… .2012.09.019

Provided by St. George's University of London search and more info website

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Genetics created May 20, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers identify new circadian clock component

Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.

Genetics created May 16, 2013 | popularity 3 / 5 (1) | comments 1 | with audio podcast

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Genetics created May 16, 2013 | popularity 5 / 5 (1) | comments 3 | with audio podcast

Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing

In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0

Experts urge caution over use of new genetic sequencing techniques

The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.